Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-03-03 @ 4:12 PM
Study NCT ID:
NCT02005068
Status:
WITHDRAWN
Last Update Posted:
2014-08-07
First Post:
2013-11-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ceftaroline in the Treatment of Bone and Joint Infections
Sponsor:
Orlando Health, Inc.
Organization:
Study Overview
Official Title:
Ceftaroline in the Treatment of Bone and Joint Infections
Status:
WITHDRAWN
Status Verified Date:
2014-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Failed to enroll any patients despite study modifications
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a study to evaluate the efficacy of Ceftaroline in the treatment of bone and joint infections.
Detailed Description:
Study evaluates the efficacy of Ceftaroline 600mg IV every 8 hours for the treatment of acute osteomyelitis and/or infected joints.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: